Skip to Main Content

Paper Details

How Many Patients Could Benefit From Pre-emptive Pharmacogenomic Testing and Decision Support? A Retrospective Study Based on Nationwide Austrian Claims Data.
Stud Health Technol Inform
4
2016
Author NameAffiliation
Matthias SamwaldCenter for Medical Statistics, and Intelligent Systems. Medical University of Vienna.
  • 1 - 1

Datasets

Release 1.2